KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,766,083 | -20.5% | 797,008 | +1.9% | 53.75% | -3.8% |
| Q2 2023 | $169,578,435 | +19.4% | 782,008 | 0.0% | 55.90% | -4.4% |
| Q1 2023 | $142,043,933 | -5.6% | 782,008 | +2.1% | 58.49% | -10.6% |
| Q4 2022 | $150,498,368 | -12.6% | 765,895 | 0.0% | 65.45% | +4.0% |
| Q3 2022 | $172,273,000 | +54.5% | 765,895 | -13.1% | 62.95% | +12.1% |
| Q2 2022 | $111,513,000 | +3.1% | 881,458 | +3.4% | 56.18% | +9.8% |
| Q1 2022 | $108,115,000 | -3.2% | 852,708 | 0.0% | 51.15% | +9.5% |
| Q4 2021 | $111,705,000 | +7.1% | 852,708 | 0.0% | 46.71% | +26.7% |
| Q3 2021 | $104,312,000 | +7.3% | 852,708 | 0.0% | 36.87% | -3.8% |
| Q2 2021 | $97,200,000 | -11.0% | 852,708 | -6.2% | 38.31% | +9.3% |
| Q1 2021 | $109,254,000 | -0.7% | 908,708 | -16.1% | 35.05% | -3.4% |
| Q4 2020 | $110,057,000 | – | 1,083,344 | – | 36.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |